GTF2H3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.103800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.932800E-01
Normal-vs-Stage2
6.228400E-01
Normal-vs-Stage3
6.662100E-02
Normal-vs-Stage4
6.192000E-01
Stage1-vs-Stage2
9.141200E-01
Stage1-vs-Stage3
7.472400E-02
Stage1-vs-Stage4
2.389600E-01
Stage2-vs-Stage3
1.287600E-01
Stage2-vs-Stage4
1.315190E-01
Stage3-vs-Stage4
8.611800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.285800E-01
Normal-vs-AfricanAmerican
9.882000E-01
Normal-vs-Asian
7.117600E-02
Caucasian-vs-AfricanAmerican
5.178600E-01
Caucasian-vs-Asian
6.060300E-02
AfricanAmerican-vs-Asian
6.323700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.398600E-01
Normal-vs-Female
5.855600E-01
Male-vs-Female
9.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.079800E-01
Normal-vs-Age(41-60Yrs)
9.001400E-01
Normal-vs-Age(61-80Yrs)
4.541400E-01
Normal-vs-Age(81-100Yrs)
8.234600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.157290E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.114350E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.458600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.696000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.379800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.009200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.048000E-01
Normal-vs-Daily Drinker
4.565800E-01
Normal-vs-Weekly Drinker
3.205800E-01
Normal-vs-Occasional Drinker
8.996800E-01
Normal-vs-Social Drinker
6.329000E-01
Non Drinker-vs-Daily Drinker
7.360000E-01
Non Drinker-vs-Weekly Drinker
9.342000E-01
Non Drinker-vs-Occasional Drinker
1.131590E-02
Non Drinker-vs-Social Drinker
2.185600E-01
Daily Drinker-vs-Weekly Drinker
8.507600E-01
Daily Drinker-vs-Occasional Drinker
9.028000E-02
Daily Drinker-vs-Social Drinker
5.058600E-01
Weekly Drinker-vs-Occasional Drinker
6.249700E-02
Weekly Drinker-vs-Social Drinker
3.780800E-01
Occasional Drinker-vs-Social Drinker
2.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.926200E-01
Normal-vs-Grade 2
1.210370E-01
Normal-vs-Grade 3
1.102580E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.977600E-01
Grade 1-vs-Grade 3
3.532000E-02
Grade 1-vs-Grade 4
2.926200E-01
Grade 2-vs-Grade 3
7.427600E-02
Grade 2-vs-Grade 4
1.210370E-01
Grade 3-vs-Grade 4
1.102580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.783000E-01
Normal-vs-NonDiabetic
4.439000E-01
Diabetic-vs-NonDiabetic
7.404000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.525500E-02
Normal-vs-NoPancreatitis
5.173400E-01
Pancreatitis-vs-NoPancreatitis
1.325590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.022200E-01
Normal-vs-N1
6.371000E-01
N0-vs-N1
7.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.569800E-01
Normal-vs-TP53-NonMutant
6.917200E-01
TP53-Mutant-vs-TP53-NonMutant
1.627040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
